TheScientist.com - Magazine of the Life Sciences, Every Day, Online
  Please Login or Register
  • Home
  • Community
  • Current Issue
  • Browse Archive
  • Careers
  • Video & Multimedia
  • Subscribe

Front Cover
Advertisement
Front Cover
Supplements
  • Life Sciences in
    the Greater
    Phila. Region
  • Schizophrenia
  • NC: State of the Life Sciences
  • Autoimmunity


Survey Series
  • Best Places to Work
  • $alary $urvey
  • Lab Web Site and
    Video Awards

The Scientist Daily
  • Science headlines delivered daily.
    Register today.

For Advertisers
  • Advertise with Us
  • Contact Ad Team
  • 2009 Media Kit



by Jonathan B Weitzman

RESEARCH ROUND-UP

Benefits of mutation
A study of bacterial colonization of the mouse gut shows that mutator alleles can provide short-term advantages and long-term disadvantages.

Email: Jonathan B Weitzman - jonathanweitzman@hotmail.com
News from The Scientist 2001, 2(1):20010402-01

Published 2 April 2001

Natural pathogenic bacteria populations can harbour mutator alleles (with high mutation rates) that may offer a selection advantage. In the March 30 Science, Giraud et al. describe a model to investigate the role of mutator alleles in influencing adaptation to complex environments in vivo (Science 2001, 291:2606-2608). They examined the colonization of the mouse gut by Escherichia coli strains with a high mutation rate due to a defective MutS protein. By examining bacteria in fecal samples they could follow total population sizes. Within the first two weeks of mouse infection, the mutator bacteria exhibit an advantage in gut colonization and adaptation. But at later stages the accumulation of deleterious mutations appears to affect bacterial competitiveness in secondary environments and transmission between hosts. Hence, high mutation rates may be beneficial for generating early adaptative mutations, but harmful once adaptation is achieved. These results provide a system to study the rapid evolution of bacterial mutations and provide insights into mutator alleles in human tumor cells.


Not yet registered? Get free access
 

The article you are attempting to read is Premium content which is only available to our online subscribers.

 
 

Email

Password

> Forgot Password?
> FAQ
> Subscribe

 
Not yet registered? Get free access
 

Subscribing to The Scientist is easy and inexpensive.

 

And you can choose from many options. Try us out with an online day pass starting at only $4.95. Or, get it all with unlimited online access to The Scientist Archive and door-to-door delivery of our monthly print magazine.

 
  Not yet registered? Get free access  
 

The Scientist also offers site licenses to institutions and organizations. When your librarian adds The Scientist to the library's collection, you can get unlimited online access through your place of work or study.
Recommend The Scientist today

 



About TS | Contact | Advertise | Editorial Advisory Board | Privacy Policy
© 1986-2008 The Scientist